2022 Q4 Form 10-K Financial Statement
#000110465923039243 Filed on March 30, 2023
Income Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
Revenue | $0.00 | $0.00 | |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $78.51K | $299.9K | |
YoY Change | |||
% of Gross Profit | |||
Research & Development | $11.37M | ||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $3.677M | ||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $326.0K | $2.578M | |
YoY Change | 101011.57% | ||
Operating Profit | -$2.578M | ||
YoY Change | |||
Interest Expense | $1.812M | $3.286M | |
YoY Change | |||
% of Operating Profit | |||
Other Income/Expense, Net | $3.286M | ||
YoY Change | |||
Pretax Income | $1.288M | $707.7K | |
YoY Change | |||
Income Tax | $369.4K | $647.7K | |
% Of Pretax Income | 28.68% | 91.53% | |
Net Earnings | $918.8K | $59.96K | |
YoY Change | |||
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.32 | ||
Diluted Earnings Per Share | $0.03 | $0.00 | |
COMMON SHARES | |||
Basic Shares Outstanding | 57.50M shares | ||
Diluted Shares Outstanding | 57.50M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $236.2M | $236.2M | |
YoY Change | 787288.3% | ||
Cash & Equivalents | $630.5K | $33.91K | |
Short-Term Investments | $235.6M | $235.6M | |
Other Short-Term Assets | $298.2K | $298.2K | |
YoY Change | |||
Inventory | |||
Prepaid Expenses | $298.2K | ||
Receivables | $3.335M | $189.00 | |
Other Receivables | $7.462K | $189.00 | |
Total Short-Term Assets | $236.5M | $236.5M | $34.10K |
YoY Change | 693492.92% | 788307.07% | |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $68.95M | ||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $0.00 | |
YoY Change | -100.0% | ||
Total Long-Term Assets | $0.00 | $0.00 | $703.1K |
YoY Change | -100.0% | -100.0% | |
TOTAL ASSETS | |||
Total Short-Term Assets | $236.5M | $236.5M | $34.10K |
Total Long-Term Assets | $0.00 | $0.00 | $703.1K |
Total Assets | $236.5M | $236.5M | $737.2K |
YoY Change | 31984.72% | 31862.45% | |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $47.92K | $47.92K | |
YoY Change | |||
Accrued Expenses | $2.035M | $2.578M | $1.600K |
YoY Change | 127105.69% | 336.99% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $7.860M | $7.860M | $714.7K |
YoY Change | 999.7% | 1007.02% | |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $7.860M | $7.860M | $714.7K |
Total Long-Term Liabilities | $0.00 | $0.00 | |
Total Liabilities | $7.860M | $7.860M | $714.7K |
YoY Change | 999.7% | 1007.02% | |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$6.925M | -$2.546K | |
YoY Change | 271880.48% | ||
Common Stock | $6.000K | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$6.924M | $228.7M | $22.45K |
YoY Change | |||
Total Liabilities & Shareholders Equity | $236.5M | $236.5M | $737.2K |
YoY Change | 31984.72% | 31862.45% |
Cashflow Statement
Concept | 2022 Q4 | 2022 | 2021 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $918.8K | $59.96K | |
YoY Change | |||
Depreciation, Depletion And Amortization | $3.677M | ||
YoY Change | |||
Cash From Operating Activities | $888.6K | -$396.1K | |
YoY Change | |||
INVESTING ACTIVITIES | |||
Capital Expenditures | $1.154M | ||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$1.058M | -$233.4M | |
YoY Change | |||
Cash From Investing Activities | -$1.058M | -$233.4M | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 454.2K | 234.4M | |
YoY Change | 781068.82% | ||
NET CHANGE | |||
Cash From Operating Activities | 888.6K | -396.1K | |
Cash From Investing Activities | -1.058M | -233.4M | |
Cash From Financing Activities | 454.2K | 234.4M | |
Net Change In Cash | 284.8K | 596.5K | |
YoY Change | 1888.49% | ||
FREE CASH FLOW | |||
Cash From Operating Activities | $888.6K | -$396.1K | |
Capital Expenditures | $1.154M | ||
Free Cash Flow | -$1.550M | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2021Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001883984 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2022 | clinu |
Threshold Business Days For Redemption Of Public Share
ThresholdBusinessDaysForRedemptionOfPublicShare
|
P10D | |
CY2022Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022 | clinu |
Number Of Shares Entitled To Each Right
NumberOfSharesEntitledToEachRight
|
0.1 | |
CY2022 | clinu |
Number Of Shares Entitled To Each Right
NumberOfSharesEntitledToEachRight
|
0.1 | |
CY2022Q4 | us-gaap |
Income Tax Examination Penalties Accrued
IncomeTaxExaminationPenaltiesAccrued
|
0 | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
001-41306 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
CLEAN EARTH ACQUISITIONS CORP. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
87-1431377 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
12600 Hill Country Blvd | |
CY2022 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Building R | |
CY2022 | dei |
Entity Address Address Line3
EntityAddressAddressLine3
|
Suite 275 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Bee Cave | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
TX | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
78738 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
800 | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
508-1531 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | |
CY2022 | dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | |
CY2022 | dei |
Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
true | |
CY2022Q2 | dei |
Entity Public Float
EntityPublicFloat
|
227200000 | |
CY2022 | dei |
Auditor Name
AuditorName
|
BDO USA, LLP | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
New York, New York | |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
243 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
630460 | |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
33912 | |
CY2022Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
298172 | |
CY2022Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
7462 | |
CY2021Q4 | us-gaap |
Other Receivables Net Current
OtherReceivablesNetCurrent
|
189 | |
CY2022Q4 | us-gaap |
Assets Held In Trust Current
AssetsHeldInTrustCurrent
|
235586028 | |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
236522122 | |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
34101 | |
CY2021Q4 | us-gaap |
Deferred Costs
DeferredCosts
|
703079 | |
CY2021Q4 | us-gaap |
Assets Noncurrent
AssetsNoncurrent
|
703079 | |
CY2022Q4 | us-gaap |
Assets
Assets
|
236522122 | |
CY2021Q4 | us-gaap |
Assets
Assets
|
737180 | |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
2035291 | |
CY2021Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
1600 | |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
47919 | |
CY2022Q4 | clinu |
Accrued Offering Costs
AccruedOfferingCosts
|
542981 | |
CY2021Q4 | clinu |
Accrued Offering Costs
AccruedOfferingCosts
|
588126 | |
CY2022Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
806170 | |
CY2021Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
125000 | |
CY2022Q4 | clinu |
Deferred Offering Costs Current
DeferredOfferingCostsCurrent
|
4427500 | |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7859861 | |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
714726 | |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
7859861 | |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
714726 | |
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
24233 | |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-6924623 | |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2546 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6923767 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22454 | |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
236522122 | |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
737180 | |
CY2022 | clinu |
Franchise Tax Expense
FranchiseTaxExpense
|
200000 | |
clinu |
Franchise Tax Expense
FranchiseTaxExpense
|
1600 | ||
CY2022 | clinu |
Bank Fees
BankFees
|
947 | |
CY2022 | us-gaap |
General Insurance Expense
GeneralInsuranceExpense
|
360142 | |
CY2022 | clinu |
Expenses For Dues And Subscriptions
ExpensesForDuesAndSubscriptions
|
203639 | |
CY2022 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
99845 | |
CY2022 | us-gaap |
Professional Fees
ProfessionalFees
|
1213772 | |
CY2022 | clinu |
Placement Services Fees
PlacementServicesFees
|
500000 | |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
946 | ||
CY2022 | us-gaap |
Operating Expenses
OperatingExpenses
|
2578345 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
2546 | ||
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2578345 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2546 | ||
CY2022 | us-gaap |
Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
|
1057978 | |
CY2022 | clinu |
Marketable Securities Realized Gain Loss Held In Trust Account
MarketableSecuritiesRealizedGainLossHeldInTrustAccount
|
2228053 | |
CY2022 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
3286031 | |
CY2022 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
707686 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-2546 | ||
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
647731 | |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
33912 | |
CY2022 | clinu |
Accretion Of Class Ordinary Shares Subject To Redemption To Redemption Value
AccretionOfClassOrdinarySharesSubjectToRedemptionToRedemptionValue
|
42756441 | |
CY2022 | clinu |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
8050000 | |
CY2022 | clinu |
Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
|
21588 | |
clinu |
Deferred Offering Costs Included In Accrued Offering Costs
DeferredOfferingCostsIncludedInAccruedOfferingCosts
|
588126 | ||
CY2022 | clinu |
Forfeiture Of Deferred Underwriter Fee Payable
ForfeitureOfDeferredUnderwriterFeePayable
|
3622500 | |
CY2022 | clinu |
Cash Paid For Taxes
CashPaidForTaxes
|
1252 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
59955 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2546 | ||
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22454 | |
CY2022 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
23227765 | |
CY2022 | clinu |
Units Issued During Period Value New Issues
UnitsIssuedDuringPeriodValueNewIssues
|
8900000 | |
CY2022 | us-gaap |
Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
|
42756441 | |
CY2022 | clinu |
Forfeiture Of Deferred Underwriting Commission
ForfeitureOfDeferredUnderwritingCommission
|
3622500 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
59955 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6923767 | |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
0 | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
25000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2546 | ||
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
22454 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
59955 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-2546 | ||
CY2022 | us-gaap |
Realized Investment Gains Losses
RealizedInvestmentGainsLosses
|
2228053 | |
CY2022 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
4000 | |
clinu |
Payment Of Related Party Costs
PaymentOfRelatedPartyCosts
|
189 | ||
clinu |
Formation Expenses
FormationExpenses
|
877 | ||
CY2022 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
298172 | |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
47919 | |
CY2022 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
2033691 | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1600 | ||
CY2022 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
7462 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-396122 | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-258 | ||
CY2022 | clinu |
Payments For Initial Investment Of Money Market Funds In Trust Account
PaymentsForInitialInvestmentOfMoneyMarketFundsInTrustAccount
|
232300000 | |
CY2022 | us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
232896440 | |
CY2022 | clinu |
Payments For Purchases Of Treasury Securities
PaymentsForPurchasesOfTreasurySecurities
|
466121947 | |
CY2022 | clinu |
Proceeds From Redemptions Of Treasury Securities
ProceedsFromRedemptionsOfTreasurySecurities
|
468350000 | |
CY2022 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
236182468 | |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-233357975 | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
25000 | ||
CY2022 | clinu |
Proceeds From Issuance Of Units
ProceedsFromIssuanceOfUnits
|
230000000 | |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
8900000 | |
CY2022 | clinu |
Payments Of Underwriting Expense
PaymentsOfUnderwritingExpense
|
4600000 | |
CY2022 | us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
906170 | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
125000 | ||
CY2022 | us-gaap |
Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
|
225000 | |
CY2022 | clinu |
Proceeds From Related Party Receivable
ProceedsFromRelatedPartyReceivable
|
189 | |
CY2022 | us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
630714 | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
115830 | ||
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
234350645 | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
34170 | ||
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
596548 | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
33912 | ||
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
33912 | |
CY2021Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
630460 | |
clinu |
Remeasurement Of Class Common Stock To Redemption Value
RemeasurementOfClassCommonStockToRedemptionValue
|
3264650 | ||
CY2022 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Note 1. Description of Organization and Business Operations</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Clean Earth Acquisitions Corp. (the “Company”) was incorporated in Delaware on May 14, 2021. The Company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of December 31, 2022, the Company had not commenced any operations. All activity from May 14, 2021 (inception) through December 31, 2022, relates to the Company’s formation and the initial public offering (“Initial Public Offering”), which is described below, and following the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering placed in the Trust Account (described below).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The registration statement for the Company’s Initial Public Offering was declared effective on February 23, 2022 (the “Effective Date”). On February 28, 2022, the Company consummated the Initial Public Offering of 23,000,000 units (“Units” or “Public Shares”) at $10.00 per Unit, generating gross proceeds of $230,000,000, which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 890,000 Private Placement Units (the “Private Units”) at a price of $10.00 per Private Unit in a private placement with Clean Earth Acquisitions Sponsor, LLC (the “Sponsor”) generating proceeds of $8,900,000 from the sale of the Private Units.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Following the closing of the Initial Public Offering on February 28, 2022, $232,300,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Units was placed in a trust account (“Trust Account”), located in the United States which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in money market funds selected by the Company meeting the conditions of Rule 2a-7(d) of the Investment Company Act, which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination, (ii) the redemption of any Public Shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (iii) the redemption of the Company’s Public Shares if the Company is unable to complete the initial Business Combination within 15 months (or up to 18 months with extensions) from February 28, 2022, the closing of the Initial Public Offering (the “Combination Period”).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. Even if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target, the Company’s stockholders prior to the Business Combination may collectively own a minority interest in the post-transaction company, depending on valuations ascribed to the target and the Company in the Business Combination transaction.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. Except as required by law or the rules of NASDAQ, the decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account. There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 4), Private Shares (as defined in Note 4) and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or do not vote at all.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Sponsor has agreed (a) to waive its redemption rights with respect to its Founder Shares, Private Shares and Public Shares held by it in connection with the completion of a Business Combination, (b) to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Shares if the Company fails to consummate a Business Combination, and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect the public stockholders’ ability to redeem or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:Hidden_ts5992RzfkW0gipkKMhpMw;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">ten</span></span> business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. There will be no redemption rights or liquidating distributions with respect to the Company’s rights or warrants, which will expire worthless if the Company fails to complete a Business Combination within the Combination Period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.10 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Business Combination Agreement</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">On October 12, 2022, the Company entered into a Business Combination Agreement (the “Business Combination Agreement”) with Alternus Energy Group Plc (the “Seller”). Pursuant to the Business Combination Agreement, we will acquire certain subsidiaries of the Seller, for up to 90,000,000 shares. Initially, we will issue 55,000,000 shares at closing (subject to a working capital adjustment capped at 1,000,000 additional shares) plus up to 35,000,000 shares subject to certain earn-out provisions, which will be deposited in escrow and will be released if certain conditions are met. The Business Combination Agreement may be terminated under certain customary </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">and limited circumstances at any time prior to the closing, including, among others, (i) by mutual written consent of the Company and the Seller, (ii) upon any injunction or other governmental order preventing the consummation of the transaction which shall have become final and non-appealable, (iii) upon a material breach of any representation, warranty, covenant or agreement (subject to an opportunity to cure, if such violation or breach is capable of being cured), (iv) if the closing has not occurred by May 26, 2023 and such failure in closing on or before such date is not due to the breach of the Business Combination Agreement by the party seeking to terminate and (v) by the Company, if the Seller fails to consummate the transaction following the satisfaction of the conditions to the Seller's closing. The Seller will be obligated to pay the Company a termination fee of $2,000,000 if the Business Combination Agreement is terminated by the Company pursuant to clause (v).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Risks and Uncertainties</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The credit and financial markets have experienced extreme volatility and disruptions due to the current conflict between Ukraine and Russia. The conflict is expected to have further global economic consequences, including but not limited to the possibility of severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increases in inflation rates and uncertainty about economic and political stability. In addition, the United States and other countries have imposed sanctions on Russia which increases the risk that Russia, as a retaliatory action, may launch cyberattacks against the United States, its government, infrastructure and businesses. Any of the foregoing consequences, including those we cannot yet predict, may cause our business, financial condition, results of operations and the price of our common shares to be adversely affected.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The financial statements do not include any adjustments that might result from the outcome of these uncertainties.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Going Concern</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">As of December 31, 2022, the Company had </span><span style="font-style:normal;font-weight:normal;">$630,460</span><span style="font-style:normal;font-weight:normal;"> of operating cash and a working capital deficit of </span><span style="font-style:normal;font-weight:normal;">$2,496,267</span><span style="font-style:normal;font-weight:normal;">. At December 31, 2022, working capital excludes the amount of Marketable Securities held in Trust Account and the amount of deferred underwriter fee payable. The Company classified the Marketable Securities held in Trust Account as a current asset as the Company has less than 12 months from the balance sheet date to consummate a Business Combination, at which point, if the Company did not find a Business Combination partner, the Company would cease to exist and the funds would be liquidated from the Trust Account. The Company classified the Deferred Underwriting Fees Payable as current liabilities as the Company has less than 12 months from the balance sheet date to consummate a Business Combination, at which point, if the Company did not find a Business Combination partner, the Company would cease to exist and the deferred underwriting commission would not be paid as the fees owed are contingent upon a successful Business Combination.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The Company’s liquidity needs through December 31, 2022 had been satisfied through a payment from the Sponsor of </span><span style="font-style:normal;font-weight:normal;">$25,000</span><span style="font-style:normal;font-weight:normal;"> for Class B common stock, par value </span><span style="font-style:normal;font-weight:normal;">$0.0001</span><span style="font-style:normal;font-weight:normal;"> per share (“Class B common stock” and shares thereof, “founder shares”), the Initial Public Offering and the issuance of the Private Units (see Note 3 and Note 4). Additionally, the Company drew on an unsecured promissory note to pay certain offering costs and a convertible promissory note with the Sponsor (see Note 4).</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">The Company has incurred and expects to continue to incur significant costs in pursuit of its financing and acquisition plans. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements. The initial stockholders, or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”, see Note 4). The Company cannot assure that its plans to consummate an initial Business Combination will be successful.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern one year from the date the financial statements are issued. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p> | |
CY2022 | clinu |
Condition For Future Business Combination Number Of Businesses Minimum
ConditionForFutureBusinessCombinationNumberOfBusinessesMinimum
|
1 | |
CY2022 | clinu |
Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
|
P185D | |
CY2022 | clinu |
Threshold Period From Closing Of Public Offering Entity Is Obligated To Complete Business Combination
ThresholdPeriodFromClosingOfPublicOfferingEntityIsObligatedToCompleteBusinessCombination
|
P15M | |
CY2022 | clinu |
Threshold Period From Closing Of Public Offering Entity Is Obligated To Extension Business Combination
ThresholdPeriodFromClosingOfPublicOfferingEntityIsObligatedToExtensionBusinessCombination
|
P18M | |
CY2022 | clinu |
Condition For Future Business Combination Use Of Proceeds Percentage
ConditionForFutureBusinessCombinationUseOfProceedsPercentage
|
0.80 | |
CY2022 | clinu |
Condition For Future Business Combination Threshold Percentage Ownership
ConditionForFutureBusinessCombinationThresholdPercentageOwnership
|
0.50 | |
CY2022 | clinu |
Condition For Future Business Combination Threshold Percentage Ownership
ConditionForFutureBusinessCombinationThresholdPercentageOwnership
|
0.50 | |
CY2022Q4 | clinu |
Condition For Future Business Combination Threshold Net Tangible Assets
ConditionForFutureBusinessCombinationThresholdNetTangibleAssets
|
5000001 | |
CY2022 | clinu |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
|
1 | |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
630460 | |
CY2022Q4 | clinu |
Working Capital
WorkingCapital
|
2496267 | |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> | |
CY2021Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | |
CY2022Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | |
CY2022 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
11500000 | |
CY2022 | clinu |
Net Loss At Beginning Of Initial Public Offering
NetLossAtBeginningOfInitialPublicOffering
|
-37034 | |
CY2022 | clinu |
Net Income Loss At Closing Of Initial Public Offering
NetIncomeLossAtClosingOfInitialPublicOffering
|
96989 | |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
59955 | |
CY2022 | clinu |
Remeasurement Of Class Common Stock To Redemption Value
RemeasurementOfClassCommonStockToRedemptionValue
|
-42756441 | |
CY2022 | us-gaap |
Temporary Equity Net Income
TemporaryEquityNetIncome
|
-42696486 | |
CY2022 | clinu |
Investments Maximum Maturity Term
InvestmentsMaximumMaturityTerm
|
P185D | |
CY2022 | clinu |
Percentage Obligation To Redeem Public Shares If Entity Does Not Complete Business Combination
PercentageObligationToRedeemPublicSharesIfEntityDoesNotCompleteBusinessCombination
|
1 | |
CY2022Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
23000000 | |
CY2022Q4 | clinu |
Share Price On Allocation Of Net Proceeds To Transaction Costs
SharePriceOnAllocationOfNetProceedsToTransactionCosts
|
10.00 | |
CY2022Q1 | clinu |
Remeasurement Of Class Common Stock To Redemption Value
RemeasurementOfClassCommonStockToRedemptionValue
|
39491791 | |
CY2021Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
0 | |
CY2022 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limits. At December 31, 2022 and 2021, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> | |
CY2022Q4 | clinu |
Maximum Number Of Demands For Registration Of Securities
MaximumNumberOfDemandsForRegistrationOfSecurities
|
2 | |
CY2022Q1 | clinu |
Underwriting Option Period
UnderwritingOptionPeriod
|
P45D | |
CY2022 | clinu |
Percentage Of Cash Underwriting Discount
PercentageOfCashUnderwritingDiscount
|
0.0200 | |
CY2022 | clinu |
Underwriter Cash Discount
UnderwriterCashDiscount
|
4600000 | |
CY2022 | clinu |
Percentage Of Deferred Cash Underwriting Discount
PercentageOfDeferredCashUnderwritingDiscount
|
0.0350 | |
CY2022Q4 | clinu |
Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
|
8050000 | |
CY2022Q4 | clinu |
Percentage Of Deferred Underwriting Commission Waived
PercentageOfDeferredUnderwritingCommissionWaived
|
0.50 | |
CY2022Q4 | clinu |
Forfeiture Of Deferred Underwriting Commission
ForfeitureOfDeferredUnderwritingCommission
|
3622500 | |
CY2022Q2 | clinu |
Related Party Transaction Expenses From Consultant Compensation
RelatedPartyTransactionExpensesFromConsultantCompensation
|
15000 | |
CY2022Q2 | clinu |
Cash Bonus For Consultant
CashBonusForConsultant
|
25000 | |
CY2022Q2 | clinu |
Additional Cash Bonus For Consultant For Business Combination
AdditionalCashBonusForConsultantForBusinessCombination
|
50000 | |
CY2022Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q1 | us-gaap |
Common Unit Authorized
CommonUnitAuthorized
|
111000000 | |
CY2022Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2022 | us-gaap |
Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
|
1 | |
CY2022Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
|
1 | |
CY2022Q4 | us-gaap |
Share Price
SharePrice
|
11.50 | |
CY2022 | clinu |
Warrants And Rights Outstanding Exercisable Term After Business Combination
WarrantsAndRightsOutstandingExercisableTermAfterBusinessCombination
|
P30D | |
CY2022Q4 | us-gaap |
Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
|
P5Y | |
CY2022 | clinu |
Maximum Threshold Period For Filing Registration Statement After Business Combination
MaximumThresholdPeriodForFilingRegistrationStatementAfterBusinessCombination
|
P20D | |
CY2022 | clinu |
Maximum Threshold Period For Registration Statement To Become Effective After Business Combination
MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination
|
P60D | |
CY2022 | clinu |
Maximum Threshold Period For Registration Statement To Become Effective After Business Combination
MaximumThresholdPeriodForRegistrationStatementToBecomeEffectiveAfterBusinessCombination
|
P60D | |
CY2022 | clinu |
Threshold Period For Calculating Fair Market Value
ThresholdPeriodForCalculatingFairMarketValue
|
P10D | |
CY2022 | clinu |
Warrant Exercise Term
WarrantExerciseTerm
|
P30D | |
CY2022 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
647731 | |
CY2022 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-499117 | |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
499117 | |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
647731 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.2100 | |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0.7053 | |
CY2022 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.9153 | |
CY2022Q4 | clinu |
Deferred Tax Assets Capitalized Start Up And Organization Cost
DeferredTaxAssetsCapitalizedStartUpAndOrganizationCost
|
499651 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
499651 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
499651 | |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
534 | |
CY2022 | clinu |
Valuation Allowance Deferred Tax Asset Increase Recorded To Income Tax Provision Amount
ValuationAllowanceDeferredTaxAssetIncreaseRecordedToIncomeTaxProvisionAmount
|
499117 | |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
499651 | |
CY2022Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | |
CY2022Q4 | us-gaap |
Income Tax Examination Interest Accrued
IncomeTaxExaminationInterestAccrued
|
0 | |
CY2022 | us-gaap |
Income Tax Examination Estimate Of Possible Loss
IncomeTaxExaminationEstimateOfPossibleLoss
|
0 | |
CY2022Q4 | us-gaap |
Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
|
235586028 |